ClinicalTrials.gg

Program

BBT002

A development code.

Its studies are mostly in Pulmonary Disease, Chronic Obstructive · Nasal Polyps, led by Bambusa Therapeutics.

Furthest: phase 2, since Feb 22, 20263 company-led studies, 3 open or runningNext primary completion: Dec 31, 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Bambusa Therapeutics33 open or runningphase 2since Feb 22, 2026Apr 18, 2025Dec 31, 2026phase 1 · NCT07288554

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Apr 18, 2025First study: phase 1 study in Pulmonary Disease, Chronic ObstructiveFirst studyNCT06944925 · 286 planned · United States, Australia, Georgia and more
  2. Dec 16, 2025Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT07288554 · 68 planned · China
  3. Feb 22, 2026Phase 2 study in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)Phase 2 reachedNCT07436949 · 64 planned · China

Ahead

  1. Dec 31, 2026Primary completion: phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT07288554
  2. Jan 31, 2027Primary completion: phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT06944925
  3. Dec 31, 2027Primary completion: phase 2 study in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)NCT07436949

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07436949Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) · China2RecruitingDec 31, 202764
NCT07288554Pulmonary Disease, Chronic Obstructive · China1RecruitingDec 31, 202668
NCT06944925Pulmonary Disease, Chronic Obstructive · United States, Australia, Georgia and more1RecruitingJan 31, 2027286

How it is read

Names in the registry

  • “BBT002”, 3 entries

Codes read as this program: BBT002.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.